NEW YORK, Nov. 5-Qiagen will market and sell products that use Epoch Bioscience's MGB Eclipse Probe gene expression chemistry, the companies said today.
Epoch will supply components exclusively to Qiagen, which will begin selling custom and standard probe systems based on the company's technology in early 2003.
Qiagen has a non-exclusive license to the components, and has pledged to reach certain sales goals as part of the agreement.
Epoch will receive access fees and royalties through the deal.
The MGB Eclipse Probe includes specialized software, proprietary dye and quencher technologies. It can be used for routine sequence analysis as well as discovery of splice variants and "problematic SNPs," the company says.